Evidence map›Paper›PMID 22270625›Full record

ArticleNature chemistry2011

A biomimetic polyketide-inspired approach to small-molecule ligand discovery.

Claudio Aquino, Mohosin Sarkar, Michael J Chalmers, Kimberly Mendes, Thomas Kodadek, Glenn C Micalizio

Abstract read
In one paragraph

Article in Nature chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Combinatorial chemistry in drug discovery.Current opinion in chemical biology · 2017
    Review
  9. Article
  10. Article
  11. Article
  12. An unusual intramolecularTetrahedron · 2016
    Article
  13. Chemical Tools To Monitor and Manipulate Adaptive Immune Responses.Journal of the American Chemical Society · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Claudio AquinoDepartment of Chemistry, The Scripps Research Institute, Scripps Florida, Jupiter, Florida 33458, USA.
Mohosin Sarkar
Michael J Chalmers
Kimberly Mendes
Thomas Kodadek
Glenn C Micalizio

Funding

Discovery and Treatment of the Early Autoimmune Reaction In Type 1 DiabetesDP3DK094309 · NIDDK · SCRIPPS FLORIDA · PI KODADEK, THOMAS J. · 2011 to 2011
$5.0M
Massively Parallel Identification of Protein LigandsR01GM090294 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F, KODADEK, THOMAS J. · 2009 to 2013
$3.8M
NHLBI NIH HHS N01-HV-00242NIDDK NIH HHS DP3 DK094309NIGMS NIH HHS R01 GM090294
6 · The paper itself

Abstract

The discovery of new compounds for the pharmacological manipulation of protein function often embraces the screening of compound collections, and it is widely recognized that natural products offer beneficial characteristics as protein ligands. Much effort has therefore been focused on 'natural product-like' libraries, yet the synthesis and screening of such libraries is often limited by one or more of the following: modest library sizes and structural diversity, conformational heterogeneity and the costs associated with the substantial infrastructure of modern high-throughput screening centres. Here, we describe the design and execution of an approach to this broad problem by merging principles associated with biologically inspired oligomerization and the structure of polyketide-derived natural products. A novel class of chiral and conformationally constrained oligomers is described (termed 'chiral oligomers of pentenoic amides', COPA), which offers compatibility with split-and-pool methods and can be screened en masse in a batch mode. We demonstrate that a COPA library containing 160,000 compounds is a useful source of novel protein ligands by identifying a non-covalent synthetic ligand to the DNA-binding domain of the p53 transcription factor.

Indexed as

BiomimeticsDrug DiscoveryLigandsPolyketidesLigandsPolyketides

Identifiers

PMID22270625
PMCPMC3266625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.